Walleye Capital
TMO icon

Walleye Capital’s Thermo Fisher Scientific TMO Stock Holding History

Walleye Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
212
-42,827
-100% -$20.6M ﹤0.01% 3867
2026
Q1 		$21.2M Buy
43,039
+28,793
+202% +$15.6M 0.09% 176
2025
Q4 		$8.25M Buy
14,246
+9,184
+181% +$5.19M 0.03% 785
2025
Q3 		$2.46M Buy
5,062
+2,671
+112% +$1.24M 0.01% 1425
2025
Q2 		$969K Sell
2,391
-21,704
-90% -$9.07M ﹤0.01% 2076
2025
Q1 		$12M Sell
24,095
-28,341
-54% -$15.3M 0.05% 371
2024
Q4 		$27.3M Buy
52,436
+5,938
+13% +$3.26M 0.07% 235
2024
Q3 		$28.8M Buy
46,498
+16,241
+54% +$9.61M 0.06% 227
2024
Q2 		$16.7M Buy
30,257
+4,188
+16% +$2.4M 0.03% 443
2024
Q1 		$15.2M Sell
26,069
-25,833
-50% -$14.5M 0.03% 568
2023
Q4 		$27.5M Buy
51,902
+3,958
+8% +$1.92M 0.06% 234
2023
Q3 		$24.3M Buy
+47,944
New +$25.5M 0.06% 195
2023
Q2 		– Sell
-300
Closed -$162K – 4882
2023
Q1 		$173K Buy
+300
New +$169K ﹤0.01% 2575

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Walleye Capital's TMO Position: Q2 2026 in Review

Walleye Capital reduced its Thermo Fisher Scientific (TMO) stake by 100% in Q2 2026, selling an estimated $20.6M and leaving 212 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3867.

Walleye Capital first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. The position peaked at $28.8M in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Walleye Capital held 212 shares of Thermo Fisher Scientific worth $106K as of Q2 2026.
  • Walleye Capital sold 42,827 Thermo Fisher Scientific shares in Q2 2026, an estimated $20.6M.
  • Thermo Fisher Scientific made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3867 holding.
  • Walleye Capital first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • Walleye Capital's Thermo Fisher Scientific position peaked at $28.8M in Q3 2024.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.